申请人:Takeda Chemical Industries, Ltd.
公开号:US05633248A1
公开(公告)日:1997-05-27
A compound of the formula: ##STR1## wherein Ar.sup.1 and Ar.sup.2 independently represent an optionally substituted aromatic group; P and Q independently represent a divalent aliphatic hydrocarbon group having at least 2 carbon atoms and optionally having either oxygen or sulfur in the carbon chain; R.sup.1 and R.sup.3 independently represent --CO--R, --CONH--R (R represents a hydrocarbon group or a heterocyclic group) or a hydrocarbon group; R.sup.2 and R.sup.4 independently represent hydrogen or an alkyl group; R.sup.2 and R.sup.4 independently represent hydrogen or an alkyl group; R.sup.1 and R.sup.2 or R.sup.3 and R.sup.4, taken together with the adjacent nitrogen atom, may form a nitrogen-containing heterocyclic group; and j represents 0 or 1, or a salt thereof, has excellent GnRH-receptor antagonizing activity and is useful as a prophylactic and therapeutic agent for hormone-dependent and other diseases.
式(I)化合物:##STR1## 其中,Ar1和Ar2各自独立地表示可任选取代的芳香族基团;P和Q各自独立地表示至少含有2个碳原子的二价脂肪族烃基,且可任选地在碳链中包含氧或硫;R1和R3各自独立地表示--CO--R、--CONH--R(R表示烃基或杂环基团)或烃基;R2和R4各自独立地表示氢或烷基;R2和R4各自独立地表示氢或烷基;R1和R2或R3和R4,与相邻的氮原子一起,可以形成含氮杂环基团;j表示0或1,或其盐,具有优异的促性腺激素释放激素(GnRH)受体拮抗活性,并可作为激素依赖性疾病及其他疾病的预防和治疗药物。